Fundraising Fox

Signatur Biosciences

YC S22 ↗

London, GB · Founded 2022 · 5 employees · 2 known investors

signatur.bio ↗

Signatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.

BiotechDigital HealthHealthtechMedical DevicesHealthcareDiagnosticsin /signatur-bio/@SignaturBioycombinator.com ↗

Founders & leadership· Y Combinator alumni (S22)

JGJohn Goertz
John Goertzin𝕏Founder
CDCelestin de Wergifosse
Celestin de Wergifossein𝕏Founder
CD
Celestin de WergifiosseCEO
PD
Prof Dame Molly StevensinScientific Advisory Board Chair, Co-inventor

Investors · 2

Myelin VCMontevideo · $250K – $1M
Y CombinatorSan Francisco · $500K

Companies House · registry record

View on Companies House ↗
Registered name
SIGNATUR BIOSCIENCES LTD
Company number
14027651
Status
Active
Company type
Private limited company
Incorporated
5 Apr 2022
Registered office
30 Upper High Street, Thame, Oxfordshire, OX9 3EZ
Nature of business (SIC)
71122 — Engineering related scientific and technical consulting activities
Accounts
last made up to 30 Apr 2025 · next due 31 Jan 2027
Confirmation statement
last made up to 4 Apr 2026 · next due 18 Apr 2027

Current officers · 1

  • Celestin De Wergifosse — director, appointed 5 Apr 2022

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news